Copyright Reports & Markets. All rights reserved.

Global and Japan Neurodegenerative Disease Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Neurodegenerative Disease Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 NMDA
    • 1.2.3 SSRIs
    • 1.2.4 Dopamine Inhibitors
  • 1.3 Market by Application
    • 1.3.1 Global Neurodegenerative Disease Market Share by Application: 2020 VS 2026
    • 1.3.2 Parkinson’s Disease
    • 1.3.3 Huntington Disease
    • 1.3.4 Amyotrophic Lateral Sclerosis
    • 1.3.5 Alzheimer’s Disease
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Neurodegenerative Disease Market Perspective (2015-2026)
  • 2.2 Global Neurodegenerative Disease Growth Trends by Regions
    • 2.2.1 Neurodegenerative Disease Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Neurodegenerative Disease Historic Market Share by Regions (2015-2020)
    • 2.2.3 Neurodegenerative Disease Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Neurodegenerative Disease Players by Market Size
    • 3.1.1 Global Top Neurodegenerative Disease Players by Revenue (2015-2020)
    • 3.1.2 Global Neurodegenerative Disease Revenue Market Share by Players (2015-2020)
  • 3.2 Global Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Neurodegenerative Disease Revenue
  • 3.4 Global Neurodegenerative Disease Market Concentration Ratio
    • 3.4.1 Global Neurodegenerative Disease Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Revenue in 2019
  • 3.5 Key Players Neurodegenerative Disease Area Served
  • 3.6 Key Players Neurodegenerative Disease Product Solution and Service
  • 3.7 Date of Enter into Neurodegenerative Disease Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Neurodegenerative Disease Breakdown Data by Type (2015-2026)

  • 4.1 Global Neurodegenerative Disease Historic Market Size by Type (2015-2020)
  • 4.2 Global Neurodegenerative Disease Forecasted Market Size by Type (2021-2026)

5 Neurodegenerative Disease Breakdown Data by Application (2015-2026)

  • 5.1 Global Neurodegenerative Disease Historic Market Size by Application (2015-2020)
  • 5.2 Global Neurodegenerative Disease Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Neurodegenerative Disease Market Size (2015-2026)
  • 6.2 North America Neurodegenerative Disease Market Size by Type (2015-2020)
  • 6.3 North America Neurodegenerative Disease Market Size by Application (2015-2020)
  • 6.4 North America Neurodegenerative Disease Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Neurodegenerative Disease Market Size (2015-2026)
  • 7.2 Europe Neurodegenerative Disease Market Size by Type (2015-2020)
  • 7.3 Europe Neurodegenerative Disease Market Size by Application (2015-2020)
  • 7.4 Europe Neurodegenerative Disease Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Neurodegenerative Disease Market Size (2015-2026)
  • 8.2 China Neurodegenerative Disease Market Size by Type (2015-2020)
  • 8.3 China Neurodegenerative Disease Market Size by Application (2015-2020)
  • 8.4 China Neurodegenerative Disease Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Neurodegenerative Disease Market Size (2015-2026)
  • 9.2 Japan Neurodegenerative Disease Market Size by Type (2015-2020)
  • 9.3 Japan Neurodegenerative Disease Market Size by Application (2015-2020)
  • 9.4 Japan Neurodegenerative Disease Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Neurodegenerative Disease Market Size (2015-2026)
  • 10.2 Southeast Asia Neurodegenerative Disease Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Neurodegenerative Disease Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Neurodegenerative Disease Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Company Details
    • 11.1.2 Novartis Business Overview
    • 11.1.3 Novartis Neurodegenerative Disease Introduction
    • 11.1.4 Novartis Revenue in Neurodegenerative Disease Business (2015-2020))
    • 11.1.5 Novartis Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Neurodegenerative Disease Introduction
    • 11.2.4 Pfizer Revenue in Neurodegenerative Disease Business (2015-2020)
    • 11.2.5 Pfizer Recent Development
  • 11.3 Merck Serono
    • 11.3.1 Merck Serono Company Details
    • 11.3.2 Merck Serono Business Overview
    • 11.3.3 Merck Serono Neurodegenerative Disease Introduction
    • 11.3.4 Merck Serono Revenue in Neurodegenerative Disease Business (2015-2020)
    • 11.3.5 Merck Serono Recent Development
  • 11.4 Biogen Idec
    • 11.4.1 Biogen Idec Company Details
    • 11.4.2 Biogen Idec Business Overview
    • 11.4.3 Biogen Idec Neurodegenerative Disease Introduction
    • 11.4.4 Biogen Idec Revenue in Neurodegenerative Disease Business (2015-2020)
    • 11.4.5 Biogen Idec Recent Development
  • 11.5 TEVA
    • 11.5.1 TEVA Company Details
    • 11.5.2 TEVA Business Overview
    • 11.5.3 TEVA Neurodegenerative Disease Introduction
    • 11.5.4 TEVA Revenue in Neurodegenerative Disease Business (2015-2020)
    • 11.5.5 TEVA Recent Development
  • 11.6 UCB
    • 11.6.1 UCB Company Details
    • 11.6.2 UCB Business Overview
    • 11.6.3 UCB Neurodegenerative Disease Introduction
    • 11.6.4 UCB Revenue in Neurodegenerative Disease Business (2015-2020)
    • 11.6.5 UCB Recent Development
  • 11.7 Boehringer Ingelheim
    • 11.7.1 Boehringer Ingelheim Company Details
    • 11.7.2 Boehringer Ingelheim Business Overview
    • 11.7.3 Boehringer Ingelheim Neurodegenerative Disease Introduction
    • 11.7.4 Boehringer Ingelheim Revenue in Neurodegenerative Disease Business (2015-2020)
    • 11.7.5 Boehringer Ingelheim Recent Development
  • 11.8 Sanofi
    • 11.8.1 Sanofi Company Details
    • 11.8.2 Sanofi Business Overview
    • 11.8.3 Sanofi Neurodegenerative Disease Introduction
    • 11.8.4 Sanofi Revenue in Neurodegenerative Disease Business (2015-2020)
    • 11.8.5 Sanofi Recent Development
  • 11.9 GlaxoSmithKline
    • 11.9.1 GlaxoSmithKline Company Details
    • 11.9.2 GlaxoSmithKline Business Overview
    • 11.9.3 GlaxoSmithKline Neurodegenerative Disease Introduction
    • 11.9.4 GlaxoSmithKline Revenue in Neurodegenerative Disease Business (2015-2020)
    • 11.9.5 GlaxoSmithKline Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Neurodegenerative Disease Scope and Market Size
    Neurodegenerative Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neurodegenerative Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    NMDA
    SSRIs
    Dopamine Inhibitors

    Market segment by Application, split into
    Parkinson’s Disease
    Huntington Disease
    Amyotrophic Lateral Sclerosis
    Alzheimer’s Disease

    Based on regional and country-level analysis, the Neurodegenerative Disease market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Neurodegenerative Disease market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Novartis
    Pfizer
    Merck Serono
    Biogen Idec
    TEVA
    UCB
    Boehringer Ingelheim
    Sanofi
    GlaxoSmithKline

    Buy now